Sign Up | Log In | What is SocialPicks?

The Rock-Star Investors Next Door

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Mike Havrilla www.BioRunUp.com

Start Tracking Mike Havrilla - Add to Friends - Send Message

Community Rank: Principal (7000 pts) | Member since 07/15/2008

Picks Performance:

Outperforms

73%

of community

What's this?

All-time Return +1.04% (in over 4 years)	Risk (SD) Moderate 0.00%	Sharpe Ratio -2.09
Followers 87	Winning Picks 786 of 1807	Total Views 2575956

Overview

Stocks

Stats

Community

Widget

Shared Picks | Personal Portfolio | Voted Picks | Commented On

View: Shared Picks (Quick) / (Detailed) | Personal Portfolio

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
MWV	N/A	11/23/08	+237.88%	+0.00%	+237.88%	YTD Analysis of Lumber Prices Vs. Timber ..	9
WY		11/23/08	-14.44%	+0.00%	-14.44%	YTD Analysis of Lumber Prices Vs. Timber ..	9
IP		11/23/08	+293.48%	+0.00%	+293.48%	YTD Analysis of Lumber Prices Vs. Timber ..	9
XOMA		11/22/08	+401.25%	+0.00%	+401.25%	Navigating the Minefield of Micro-Cap Bio..	1
CYTK	N/A	11/22/08	-38.33%	+0.00%	-38.33%	Navigating the Minefield of Micro-Cap Bio..	9
TARG	N/A	11/21/08	+100.00%	+0.00%	+100.00%	Updated FDA Calendar of 75 Decision Dates..	9
TSM		11/20/08	+200.98%	+0.00%	+200.98%	Former Wall Street Favorites Sink to Sing..	9
EMC		11/20/08	+151.34%	+0.00%	+151.34%	Former Wall Street Favorites Sink to Sing..	9
AMAT		11/20/08	+81.98%	+0.00%	+81.98%	Former Wall Street Favorites Sink to Sing..	9
MOT		11/20/08	n/a	+0.00%	n/a	Former Wall Street Favorites Sink to Sing..	9
C		11/20/08	+706.53%	+0.00%	+706.53%	Former Wall Street Favorites Sink to Sing..	9
PGN		11/19/08	n/a	+0.00%	n/a	Dissecting Defensive Dividend Stocks & ET..	9
KMP		11/19/08	+63.99%	+0.00%	+63.99%	Dissecting Defensive Dividend Stocks & ET..	9
DUK		11/19/08	+326.86%	+0.00%	+326.86%	Dissecting Defensive Dividend Stocks & ET..	9
REP		11/19/08	n/a	+0.00%	n/a	Dissecting Defensive Dividend Stocks & ET..	9
SCMWY	N/A	11/19/08	+52.60%	+0.00%	+52.60%	Dissecting Defensive Dividend Stocks & ET..	9
TLSYY	N/A	11/19/08	+66.21%	+0.00%	+66.21%	Dissecting Defensive Dividend Stocks & ET..	9
DVY		11/19/08	+56.01%	+0.00%	+56.01%	Dissecting Defensive Dividend Stocks & ET..	9
MBT		11/18/08	-32.30%	+0.00%	-32.30%	New Global Telecom Index Connects Investo..	9
VIP		11/18/08	+3.24%	+0.00%	+3.24%	New Global Telecom Index Connects Investo..	9

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
next »

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
NBS		06/04/09	-11.54%	+0.00%	-11.54%	NeoStem (AMEX:NBS): Pro-Active Research I..	9
PSDV	N/A	04/08/09	+77.27%	+0.00%	+77.27%	Updated FDA, Clinical Trial Calendars: AZ..	9
JAV		03/15/09	+7.83%	+0.00%	+7.83%	Javelin Pharma: Late-Stage Pipeline Targe..	9
BPAX		01/13/09	+64.30%	+0.00%	+64.30%	In Search of Healthcare Diamonds in the R..	9
BMTI	N/A	02/25/09	+1.56%	+0.00%	+1.56%	Global Stem Cell and Regenerative Medicin..	9
DYAX		06/08/09	-5.63%	+0.00%	-5.63%	FDA Calendar Updates: MITI, KERX, GSK, DY..	9
LLY		05/21/09	-3.44%	+0.00%	-3.44%	FDA, Clinical Trial Updates: GENZ, HGSI, ..	9
GTXI		04/23/09	-11.08%	+0.00%	-11.08%	FDA, Clinical Trial Calendar Updates: Aco..	9
GSK		06/08/09	+8.41%	+0.00%	+8.41%	FDA Calendar Updates: MITI, KERX, GSK, DY..	9
BDSI		06/12/09	+0.63%	+0.00%	+0.63%	FDA Calendar Updates: BDSI, SVNT Deadline..	9
INSM		05/13/09	+67.97%	+0.00%	+67.97%	FDA, Clinical Trial Calendar Updates: Ins..	9
AMAG		05/12/09	-8.32%	+0.00%	-8.32%	FDA, Clinical Trial Calendar Updates: AMA..	9
SVNT		06/12/09	+0.00%	+0.00%	+0.00%	FDA Calendar Updates: BDSI, SVNT Deadline..	9
HGSI		06/12/09	+0.00%	+0.00%	+0.00%	FDA Calendar Updates: BDSI, SVNT Deadline..	10
HGSI		03/15/09	-319.74%	+0.00%	-319.74%	Updated Clinical Trial and FDA Decision C..	1
TSPT	N/A	04/09/09	-82.96%	+0.00%	-82.96%	A Dozen Extreme FDA Trades on New Product..	9
OSTE	N/A	02/22/09	+34.31%	+0.00%	+34.31%	Global Stem Cell Index Down 9% Last Week..	9
SVNT		02/28/09	-41.53%	+0.00%	-41.53%	Updated Clinical Trial and FDA Decision C..	9
BDSI		06/01/09	+15.34%	+0.00%	+15.34%	13 Extreme FDA Trades: BioMedReports.com ..	9
ACCP		05/27/09	n/a	+0.00%	n/a	Access Pharma: A Cancer Biotech Call Opti..	1

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
next »

Similarity to Me ?

Compare Your Portfolio With Mike Havrilla: Enter stocks you like & track your performance:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Mike Havrilla

Investment Style:
Aggressive [?]

Avg exp holding time:
384.53 days

Age: 30's
Location: USA

Website:
www.BioRunUp.com

About Me:

I am a pharmacist, writer, marathon runner, and investor. Check out the Ultimate Guide to Biotech Sto ... more

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.